Bold claim: space could become the new workshop for artificial retinas. And this is exactly where the discussion starts to get intriguing—and a bit controversial.
Prognosis
December 12, 2025 at 11:00 AM UTC
Hello reader, I’m Lisa from London. I’ve been digging into the idea that the space environment might offer advantages for manufacturing artificial retinas. But before we dive into the specifics, a quick personal note behind my curiosity: I’ve begun exploring how the eye works more deeply after developing light sensitivity issues linked to my long COVID experience. This led me to a biotech company that’s pursuing artificial retinas produced in space, with the aim of treating certain retinal diseases on Earth. I was eager to understand what makes this approach compelling and what challenges it might face.
Why space, you might ask? In microgravity, some biomanufacturing processes can proceed differently—sometimes more cleanly or with unique material properties that are hard to achieve on Earth. For artificial retinas, the idea is that the space setting could support cell growth, device integration, or coating processes in ways that improve quality or yield. The potential benefits aren’t just theoretical: advancing these manufacturing methods could make treatments more accessible and effective for people suffering from retinal diseases here on our planet.
If you’re curious about the concrete steps, the plan typically involves developing retinal cells or synthetic components in a controlled space environment, then validating their performance back on Earth. The ultimate goal is to translate any manufacturing edge discovered in space into safer, more reliable implants for patients affected by retinal conditions.
To learn more about the specific company and their progress, you can explore publicly available updates from the seed-round announcements and preclinical study plans linked in the original reporting.
